Related Experiment Video
Updated: Nov 9, 2025

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
Infective endocarditis in paediatric population
Loay Eleyan1, Ameer Ahmed Khan1, Gledisa Musollari2
1School of Medicine, Faculty of Health and Life Science, University of Liverpool, Liverpool, UK.
Insights
Pediatric infective endocarditis, often linked to congenital heart defects, requires prompt diagnosis using modified Duke criteria and advanced imaging. Current research focuses on improving long-term outcomes and quality of life through updated medical and surgical interventions.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Infective endocarditis (IE) is rare in children but carries severe risks, with congenital heart defects being a primary risk factor.
- Staphylococcus aureus and viridans streptococci are common pathogens, presenting diverse symptoms that complicate diagnosis.
- Current diagnostic approaches rely on modified Duke criteria, blood cultures, serology, and advanced imaging.
Purpose of the Study:
- To review current diagnostic and management strategies for pediatric infective endocarditis.
- To compare American Heart Association (AHA) and European Society of Cardiology (ESC) guidelines for pediatric IE.
- To highlight advancements and future research needs in managing this high-risk pediatric cohort.
Main Methods:
- Literature review comparing AHA and ESC guidelines.
- Analysis of diagnostic techniques including modified Duke criteria, blood cultures, serology, imaging (echocardiograms, CT, PET), and biomarkers (CRP, IL-15, CXCL).
- Evaluation of medical (antimicrobial) and surgical (valve repair/replacement) interventions.
Main Results:
- Modified Duke criteria and blood cultures are key for diagnosis; serology is vital for blood culture-negative cases.
- Biomarkers like CRP, IL-15, and CXCL show promise for risk prediction.
- Surgical intervention significantly improves quality of life for pediatric IE patients.
Conclusions:
- Significant progress has been made in diagnosing and managing pediatric infective endocarditis.
- Further research is needed to optimize long-term outcomes and quality of life for affected children.
- A multidisciplinary approach integrating diagnostics, medical, and surgical interventions is crucial.
Abstract:
Infective endocarditis is very uncommon in children; however, when it does arise, it can lead to severe consequences. The biggest risk factor for paediatric infective endocarditis today is underlying congenital heart defects. The most common causative organisms are Staphylococcus aureus and the viridans group of streptococci. The spectrum of symptoms varies widely in children and this produces difficulty in the diagnosis of infective endocarditis. Infective endocarditis in children is reliant on the modified Duke criteria. The use of blood cultures remains the most effective microbiological test for pathogen identification. However, in blood culture-negative infective endocarditis, serology testing and IgG titres are more effective for diagnosis. Imaging techniques used include echocardiograms, computed tomography and positron emission tomography. Biomarkers utilised in diagnosis are C-reactive protein, with recent literature reviewing the use of interleukin-15 and C-C motif chemokine ligand for reliable risk prediction. The American Heart Association (AHA) and European Society of Cardiology (ESC) guidelines have been compared to describe the differences in the approach to infective endocarditis in children. Medical intervention involves the use of antimicrobial treatment and surgical interventions include the repair and replacement of cardiac valves. Quality of life is highly likely to improve from surgical intervention.Conclusion: Over the past decades, there have been great advancements in clinical practice to improve outcomes in patients with infective endocarditis. Nonetheless, further work is required to better investigative and manage such high risk cohort. What is Known: • The current diagnostic techniques including 'Duke's criteria' for paediatric infective endocarditis diagnosis • The current management guidelines utilised for paediatric infective endocarditis What is New: • The long-term outcomes of patients that underwent medical and surgical intervention • The quality of life of paediatric patients that underwent medical and surgical intervention.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Rheumatic Heart Disease I: Introduction
Myocarditis III: Medical Management

